Search

everythinglearnresearchcommunity

for

Search:↓

Male gender and family history predict alopecia areata recurrence.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

One Ashwagandha extract may help protect cells with its antioxidant properties, while another could promote hair growth.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Some traditional Chinese medicines may have anti-aging benefits and could help with hair growth, but more research is needed.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 infection is highly related to increased hair loss, especially in women.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

Redefining drug dosages is crucial when repurposing them for new uses.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.